Diagnosis, risk factors and management of diabetes mellitus in HIV-infected persons in France: A real-life setting study

Archive ouverte

Kousignian, Isabelle | Sautereau, Aurélie | Vigouroux, Corinne | Cros, Agnès | Kretz, Sandrine | Viard, Jean, Paul | Slama, Laurence

Edité par CCSD ; Public Library of Science -

International audience. Background: Diabetes mellitus (DM) is a major and increasing public health problem that may be underdiagnosed and undertreated among persons living with HIV (PLWH).Objective: To describe the diagnosis, treatment and follow-up of DM among PLWH.Methods: This study was performed inside a monocentric cohort of 1494 PLWH. DM was defined as having a FG ≥126 mg/dL twice or a HbA1c ≥6.5%, or a history of diabetes, or receiving antidiabetic treatment. The first visit mentioning a diagnosis of DM was considered as the baseline visit. Chi-Square or Fisher exact test were used to examine the association between categorical variables and DM, Wilcoxon or Student t-test were used for continuous variables.Results: 156 PLWH with DM were included. Compared to non-diabetic participants, they were more likely to be native of Sub Saharan Africa (31.6% vs. 22.4%, p = 0.027) and older (54.6 vs. 49.9 years, p<0.001), to have a higher BMI (> 25 for 46.1% vs. 35.3%, p = 0.020) and a poorer control of HIV (HIV RNA<50 copies/mL: 80.1% vs. 89.5%, p<0.001). The diagnosis of DM was missed in 37.8% of PLWH, and 47.2% of PLWH treated for DM did not reach a HbA1c<7%. PLWH with DM were more frequently on antihypertensive and/or lipid-lowering medications: 94.2% had a LDL-cholesterol <70 mg/dL and 60.9% had a blood pressure <140/90 mmHg.Conclusion: In a setting of HIV-control, HIV care providers should focus on metabolic issues. The management of DM and associated risk factors is mandatory to prevent cardiovascular disease in PLWH.

Suggestions

Du même auteur

Comparison of the immunological and virological responses to cART between HIV-1/O and HIV-1/M patients followed up in France

Archive ouverte | Unal, Guillemette | CCSD

International audience. Abstract Background Therapeutic outcomes for patients infected by genetically divergent HIV-1/O are not well-known due to scarce data and the lack of an appropriate comparison with patients i...

A 4-days-on and 3-days-off maintenance treatment strategy for adults with HIV-1 (ANRS 170 QUATUOR): a randomised, open-label, multicentre, parallel, non-inferiority trial

Archive ouverte | Landman, Roland | CCSD

International audience

Perspectives of injectable long acting antiretroviral therapies for HIV treatment or prevention: understanding potential users’ ambivalences

Archive ouverte | Carillon, Séverine | CCSD

International audience

Chargement des enrichissements...